Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × fosbretabulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Carcinoma, Anaplastic 4 Thyroid Neoplasms 3 Neuroendocrine Tumors 3 Neoplasms 3 Head and Neck Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoid Tumor 1

Interventions

Carboplatin 286 Paclitaxel 282 Bevacizumab 151 pembrolizumab 94 liposomal doxorubicin 89 Gemcitabine 86 Cyclophosphamide 83 olaparib 82 Cisplatin 80 Topotecan 77 niraparib 62 Docetaxel 50 Doxorubicin 46 Taxes 39 Drug Therapy 39 fludarabine 36 Nivolumab 34 Filgrastim 31 Specimen Handling 30 Magnetic Resonance Spectroscopy 28 Hyperthermic Intraperitoneal Chemotherapy 28 Etoposide 28 Surveys and Questionnaires 27 Blood Specimen Collection 25 Peripheral Blood Stem Cell Transplantation 23 durvalumab 22 Immunoglobulin G 22 Disulfides 22 Cytoreduction Surgical Procedures 22 Biopsy 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02055690 2021-05-17

PAZOFOS

The Christie NHS Foundation Trust

Phase 1/2 Terminated

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡